journal article·2017-02-13

Polyanhydride Nanoparticle Interactions with Host Serum Proteins and Their Effects on Bone Marrow Derived Macrophage Activation

Julia E. Vela Ramirez, Paola M. Boggiatto, Michael J. Wannemuehler, Balaji Narasimhan

Publisher page

Abstract

An in-depth understanding of the interactions of vaccine delivery vehicles with antigen presenting cells is important for tailoring optimal adjuvant properties. Polymeric nanoparticles have been widely studied as adjuvants and delivery vehicles; however, there is little information regarding the effect of serum protein adsorption onto biomaterials and the effect of this adsorption upon interactions with antigen presenting cells. The current studies analyzed effects of polyanhydride chemistry on serum adsorption to nanoparticles with respect to their uptake by and activation of bone marrow-derived macrophages. Differential effects of serum adsorption based on nanoparticle chemistry were shown to enhance (for 1,6-bis( p -carboxyphenoxy)hexane and sebacic anhydride-based) or reduce (for 1,6-bis( p -carboxyphenoxy)hexane and 1,8-bis( p -carboxyphenoxy)-3,6-dioxaoctane-based) nanoparticle uptake. The observed complex interdependence between nanoparticle chemistry and serum protein adsorption on macrophage activation provided insights that will facilitate the rational design of single-dose nanovaccines developed to induce robust immune responses.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · RNA Interference and Gene Delivery · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical and Biological Engineering, Iowa State University, Ames, Iowa 50011, United States

Department of Veterinary Microbiology and Preventive Medicine, Iowa State University, Ames, Iowa 50011, United States

Funding

National Institute of Allergy and Infectious Diseases · Iowa State University

References (61)

Show source-provided references
1. 10.1016/S0065-2776(07)96005-810.1016/S0065-2776(07)96005-8 ↗
2. 10.1038/ni.293910.1038/ni.2939 ↗
3. 10.1146/annurev.immunol.17.1.59310.1146/annurev.immunol.17.1.593 ↗
4. 10.1002/ppsc.20140014810.1002/ppsc.201400148 ↗
5. 10.1146/annurev-bioeng-082615-03051910.1146/annurev-bioeng-082615-030519 ↗
6. 10.1021/ja208433810.1021/ja2084338 ↗
7. 10.1073/pnas.060858210410.1073/pnas.0608582104 ↗
8. 10.1016/j.clim.2015.06.01210.1016/j.clim.2015.06.012 ↗
9. 10.1371/journal.pone.006098910.1371/journal.pone.0060989 ↗
10. 10.1038/nri358210.1038/nri3582 ↗
11. 10.1038/srep0019810.1038/srep00198 ↗
12. 10.1002/polb.2225910.1002/polb.22259 ↗
13. 10.1002/jbm.a.3054510.1002/jbm.a.30545 ↗
14. 10.1080/09205063.2014.94024310.1080/09205063.2014.940243 ↗
15. 10.1371/journal.pone.001764210.1371/journal.pone.0017642 ↗
16. 10.1016/j.biomaterials.2012.03.02710.1016/j.biomaterials.2012.03.027 ↗
17. 10.1016/j.actbio.2011.03.02310.1016/j.actbio.2011.03.023 ↗
18. 10.1016/j.actbio.2012.06.00110.1016/j.actbio.2012.06.001 ↗
19. 10.1039/C4NR03724C10.1039/C4NR03724C ↗
20. 10.1142/S233954781450016210.1142/S2339547814500162 ↗
21. 10.1002/jbm.b.3282010.1002/jbm.b.32820 ↗
22. 10.1002/jbm.b.3147810.1002/jbm.b.31478 ↗
23. Conix A. · Macromol. Synth · 1966 · 2 · 95
24. 10.1002/jbm.a.3051010.1002/jbm.a.30510 ↗
25. 10.1016/S0142-9612(00)00175-710.1016/S0142-9612(00)00175-7 ↗
26. 10.1016/S0142-9612(02)00181-310.1016/S0142-9612(02)00181-3 ↗
27. 10.1002/jbm.a.3508610.1002/jbm.a.35086 ↗
28. 10.1007/s11095-008-9760-710.1007/s11095-008-9760-7 ↗
29. 10.1016/j.micinf.2006.07.00510.1016/j.micinf.2006.07.005 ↗
30. 10.1084/jem.170.5.163510.1084/jem.170.5.1635 ↗
31. 10.1016/j.biomaterials.2011.05.06310.1016/j.biomaterials.2011.05.063 ↗
32. 10.1016/j.biomaterials.2009.05.06910.1016/j.biomaterials.2009.05.069 ↗
33. 10.1039/C1CS15233E10.1039/C1CS15233E ↗
34. 10.1002/elps.20040603910.1002/elps.200406039 ↗
35. 10.1093/nar/gkr112210.1093/nar/gkr1122 ↗
36. 10.1007/bf0028145810.1007/bf00281458 ↗
37. 10.1093/nar/gks106810.1093/nar/gks1068 ↗
38. 10.1021/pr049921p10.1021/pr049921p ↗
39. 10.1016/j.addr.2009.03.00910.1016/j.addr.2009.03.009 ↗
40. 10.1186/1477-5956-6-2510.1186/1477-5956-6-25 ↗
41. 10.1021/mp200213r10.1021/mp200213r ↗
42. 10.1016/j.coi.2010.02.01310.1016/j.coi.2010.02.013 ↗
43. 10.1016/j.addr.2014.05.01110.1016/j.addr.2014.05.011 ↗
44. 10.1016/j.copbio.2013.02.01510.1016/j.copbio.2013.02.015 ↗
45. 10.1128/MMBR.66.4.617-629.200210.1128/MMBR.66.4.617-629.2002 ↗
46. 10.1111/1574-6968.1234910.1111/1574-6968.12349 ↗
47. 10.1038/nature0624610.1038/nature06246 ↗
48. 10.1038/nrmicro212810.1038/nrmicro2128 ↗
49. 10.1016/j.coi.2010.01.01610.1016/j.coi.2010.01.016 ↗
50. 10.1016/j.coi.2010.01.02210.1016/j.coi.2010.01.022 ↗
51. 10.1038/nri340510.1038/nri3405 ↗
52. 10.1038/nri244810.1038/nri2448 ↗
53. 10.1146/annurev.immunol.23.021704.11581610.1146/annurev.immunol.23.021704.115816 ↗
54. 10.1038/nri97810.1038/nri978 ↗
55. 10.1021/la104720n10.1021/la104720n ↗
56. Roselaar S. E. · J. Lipid Res. · 1998 · 39 · 174010.1016/S0022-2275(20)32160-X ↗
57. 10.1016/S1568-9972(01)00018-010.1016/S1568-9972(01)00018-0 ↗
58. 10.1007/s11095-011-0624-110.1007/s11095-011-0624-1 ↗
59. 10.1529/biophysj.104.05507910.1529/biophysj.104.055079 ↗
60. 10.1016/j.ijpharm.2005.06.02510.1016/j.ijpharm.2005.06.025 ↗
61. 10.3390/pharmaceutics501003610.3390/pharmaceutics5010036 ↗